Overview The Effect of BIIL 284 BS on Induced-sputum Variables in Patients With Bronchial Asthma Status: Completed Trial end date: 1969-12-31 Target enrollment: Participant gender: Summary Study to evaluate the anti-inflammatory effect of BIIL 284 BS compared with placebo in patients with asthma Phase: Phase 2 Details Lead Sponsor: Boehringer Ingelheim